n n n n n
Nurse Prescribers, 5th Edition, Teri Moser Woo, Marylo
n n n n n n n n
u
Pharmacotherapeutics for Advanced P n n n
ractice Nurse Prescribers 5th EditionW
n n n n n
oo Robinson Test Bank
n n n
,Test Bank: Pharmacotherapeutics for Advanced Practice
n n n n n
Nurse Prescribers, 5th Edition, Teri Moser Woo, Marylo
n n n n n n n n
u
PharmacotherapeuticsnfornAdvancednPracticenNursenPrescribersn5thn Editionn Woon Robinsonn Test n Bank
Chaptern1.nThenRolenof nthenNursenPractitionern
MultiplenChoice
Identifyn then choicen thatn bestn completesn then statementn orn answersn then question.
n nnn 1.n Nursen practitionern prescriptiven authorityn isn regulated n by:
1. Then Nationaln Counciln of n Staten Boardsn of n Nursing
2. Then U.S.n Drugn Enforcement n Administration
3. Then Staten Board n of n Nursingn forn eachn state
4. Then Staten Board n of n Pharmacy
n
nnn 2.n Then benefitsn tonthenpatient nof nhavingn annAdvancednPracticen Registered n Nursen (APRN)n presc
riberninclude:
1. Nursesn know n moren about n Pharmacologyn thann othernprescribersn becausen theyn takenitnb
othn inn theirn basicn nursingn programn and n inn theirn APRN n program.
2. Nursesn caren forn then patient nfromn anholisticn approachn and nincludenthenpatient ninnd
ecisionn makingn regardingn theirn care.
3. APRNsn aren lessn likelyn ton prescriben narcoticsn and n othern controlled n substances.
4. APRNsn aren ablen ton prescriben independentlyninn alln states,nwhereasn an physician’sna
ssistant n needsn ton haven an physiciann supervisingn theirn practice.
n nnn 3.n Clinicaln judgment n inn prescribingn includes:
1. Factoringn inn then cost n ton then patient n of n then medicationn prescribed
2. Alwaysn prescribingn then newest n medicationn availablen forn then diseasen process
3. Handingn out n drugn samplesn ton poorn patients
4. Prescribingn alln genericn medicationsn ton cut n costs
n nnn 4.n Criterian forn choosingn ann effectiven drugn forn an disordern include:
1. Askingn then patient n what n drugn theyn thinkn would n workn best n forn them
2. Consultingn nationallyn recognized n guidelinesn forn diseasen management
3. Prescribingn medicationsn that n aren availablen asn samplesn beforen writingn an prescription
4. Followingn U.S.n Drugn Enforcement n Administrationn guidelinesn forn prescribing
n nnn 5.n Nursen practitionern practicen mayn thriven undern health-caren reformn becausen of:
1. Then demonstrated n abilityn of nnursen practitionersn toncontroln costsnandn improvenpatientno
utcomes
2. Then fact n that n nursen practitionersn willn ben ablen ton practicen independently
3. Then fact n that n nursen practitionersn willn haven fulln reimbursement n undern health-
carenreform
4. Then abilityn ton shift n accountabilityn forn Medicaid n ton then staten level
,Test Bank: Pharmacotherapeutics for Advanced Practice
n n n n n
Nurse Prescribers, 5th Edition, Teri Moser Woo, Marylo
n n n n n n n n
u
, Test Bank: Pharmacotherapeutics for Advanced Practice
n n n n n
Nurse Prescribers, 5th Edition, Teri Moser Woo, Marylo
n n n n n n n n
u
Chaptern1.nThenRolenof nthenNursenPractitionern
AnswernSection
MULTIPLEnCHOICE
1. ANS:nnn 3 PTS:n 1
2. ANS:nnn 2 PTS:n 1
3. ANS:nnn 1 PTS:n 1
4. ANS:nnn 2 PTS:n 1
5. ANS:nnn 1 PTS:n 1
Chaptern2.nReview nof nBasicnPrinciplesnof nPharmacologyn
MultiplenChoice
Identifyn then choicen thatn bestn completesn then statementn orn answersn then question.
n
nnn 1.n A n patient’sn nutritionaln intaken and n laboratoryn resultsn reflect n hypoalbuminemia.n Thisn isn critic
aln tonprescribingn because:
1. Distributionn of n drugsn ton target n tissuen mayn ben affected.
2. Then solubilityn of n then drugn willn not n matchn then siten of n absorption.
3. Theren willn ben lessn freen drugn availablen ton generaten ann effect.
4. Drugsn bound n ton albuminn aren readilyn excreted n byn then kidneys.
n nnn 2.n Drugsn that n haven an significant n first-passn effect:
1. Must n ben givenn byn then enteraln (oral)n routen only
2. Bypassn then hepaticn circulation
3. Aren rapidlyn metabolized n byn then livern and n mayn haven littlen if n anyn desired naction
4. Aren converted n byn then livern ton moren activen and n fat-solublen forms
n nnn 3.n Then routen of n excretionn of n an volatilen drugn willn likelyn ben the:
1. Kidneys
2. Lungs
3. Bilen and n feces
4. Skin
n
nnn 4.n Medroxyprogesteronen (DeponProvera)n isn prescribed n intramuscularlyn (IM)n ton createn ansto
ragenreservoirn of n then drug.n Storagen reservoirs:
1. Assuren that n then drugn willn reachn itsn intended n target n tissue
2. Aren then reasonn forn givingn loadingn doses
3. Increasen then lengthn of n timen an drugn isn availablen and n active
4. Aren most n commonn inn collagenn tissues
n nnn 5.n Then NPn choosesn ton given cephalexinn everyn 8n hoursn based n onn knowledgen of n then drug’s:
1. Propensityn ton gon ton then target n receptor
2. Biologicaln half-life
3. Pharmacodynamics
4. Safetyn and n siden effects